Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Potential use of Doxil in the treatment of mesothelioma

Oct. 7, 2002

Viventia options novel immunotoxin from U. of Zurich

Oct. 4, 2002

Aastrom and Stanford University collaborate on cell-based treatment for multiple myeloma

Oct. 4, 2002

AC-7700 reduces tumor blood flow and inhibits tumor growth in rats

Oct. 4, 2002

New trial of Genasense plus Gleevec in Gleevec-resistant CML patients

Oct. 3, 2002

Optimer acquires license to Globo H vaccine

Oct. 3, 2002

Early phase III enrollment for extended-release Eligard

Oct. 3, 2002

Integrin antagonists covered by 3-Dimensional patent

Oct. 3, 2002

New metal complexes as prodrugs of antitumor compounds

Oct. 3, 2002

Geron receives award for ongoing development of telomerase inhibitors for cancer

Oct. 3, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 13, 2026.
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...